Challenges and Facilitators of Implementing a Physician-approved Naloxone Protocol: A Mixed-methods Study

医学 (+)-纳洛酮 药店 协议(科学) 立法 家庭医学 机构审查委员会 医疗急救 类阿片 精神科 替代医学 法学 政治学 受体 病理 内科学
作者
Ana L. Hincapie,Michael Hegener,Pamela C. Heaton,Gabrielle Fish,Kathryn Fetters,Gregory T. Sneed,Kathleen Koechlin,Jolene DeFiore-Hyrmer,Amy Holthusen,Neil J. MacKinnon
出处
期刊:Journal of Addiction Medicine [Ovid Technologies (Wolters Kluwer)]
卷期号:15 (1): 40-48 被引量:10
标识
DOI:10.1097/adm.0000000000000672
摘要

Objectives: In 2015, the State of Ohio passed legislation to allow pharmacists to dispense naloxone under a physician-approved protocol. The legislation allows all individuals authorized under a physician-approved protocol to personally furnish naloxone without requiring clients to be seen by a licensed prescriber, thus expanding the capacity of Ohio's community distribution programs. We aimed to evaluate the implementation of legislation allowing for a physician-approved protocol in pharmacies and other naloxone distribution sites in Ohio, and to compare barriers and facilitators of implementing the law changes among sites that implemented a physician-approved protocol versus sites that did not. Methods: The study used a convergent parallel mixed-method design. Random samples from all pharmacies registered with the State of Ohio Board of Pharmacy and community naloxone distribution sites were selected. Quantitative data were collected via survey (n = 168) and qualitative data were collected via semi-structured interviews (n = 17). Results: Most survey respondents agreed that the policy has expanded access to naloxone at their site for individuals who want or need the medication. Both pharmacies and other naloxone distribution sites identified that leadership and organizational support facilitated protocol implementation and cost, stigma, and lack of naloxone demand challenged protocol implementation. Conclusions: The study identified barriers and facilitators to the implementation of a physician-approved protocol within Ohio. The majority of respondents stated they could implement a protocol. However, barriers of cost, lack of public awareness of naloxone availability, and stigma remain for pharmacies and other naloxone distribution sites.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
顺心向松发布了新的文献求助30
1秒前
乐乐应助Yuuki采纳,获得10
1秒前
橙梨苹发布了新的文献求助10
2秒前
袁小二完成签到,获得积分10
2秒前
美满的红酒完成签到 ,获得积分10
2秒前
lizi发布了新的文献求助10
3秒前
3秒前
LEOJAY发布了新的文献求助10
4秒前
Yang发布了新的文献求助10
4秒前
寻道图强应助花开的声音采纳,获得50
4秒前
4秒前
5秒前
清枫发布了新的文献求助10
5秒前
上官若男应助倦梦还采纳,获得10
5秒前
starscars完成签到 ,获得积分10
5秒前
12345完成签到,获得积分20
6秒前
奋斗不二发布了新的文献求助10
6秒前
量子星尘发布了新的文献求助10
6秒前
啦啦啦123发布了新的文献求助10
7秒前
Arpiar完成签到,获得积分10
7秒前
victor123发布了新的文献求助10
7秒前
森屿发布了新的文献求助10
7秒前
Li发布了新的文献求助10
7秒前
ShellyMaya完成签到 ,获得积分10
8秒前
晓凡发布了新的文献求助10
9秒前
华仔应助12345采纳,获得10
9秒前
Akim应助美好斓采纳,获得10
10秒前
科研通AI6应助weidingge2011采纳,获得10
11秒前
11秒前
12秒前
12秒前
永葆一颗童心完成签到,获得积分10
14秒前
雪L完成签到,获得积分10
14秒前
顾矜应助科研通管家采纳,获得10
15秒前
传奇3应助科研通管家采纳,获得10
15秒前
852应助科研通管家采纳,获得10
15秒前
英俊的铭应助科研通管家采纳,获得10
15秒前
852应助科研通管家采纳,获得10
15秒前
Yolo应助科研通管家采纳,获得10
15秒前
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Theoretical modelling of unbonded flexible pipe cross-sections 2000
List of 1,091 Public Pension Profiles by Region 1581
Encyclopedia of Agriculture and Food Systems Third Edition 1500
Specialist Periodical Reports - Organometallic Chemistry Organometallic Chemistry: Volume 46 1000
Current Trends in Drug Discovery, Development and Delivery (CTD4-2022) 800
The Scope of Slavic Aspect 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5528154
求助须知:如何正确求助?哪些是违规求助? 4617769
关于积分的说明 14560217
捐赠科研通 4556495
什么是DOI,文献DOI怎么找? 2496966
邀请新用户注册赠送积分活动 1477228
关于科研通互助平台的介绍 1448548